$VVOS and $CELV just announced the launch of its slim cell line . This product has 5x the SOD2 and 2x the Fibersol .It has been shown to reduce weight in clinical trials and waist circumference.
This is the main product $VVOS will successfully market to people that are initially getting tested for sleep apnea. It is the perfect complimentary product for GLP signaling weight loss drugs.
The sleep apnea patients all suffer from massive imbalance of oxidative stress.
This product should tack on additional .50 cent EPS for $VVOS in 2025 and well over $1.00 added EPS in 2026.. $VVOS share price heading significantly higher.
Link:
https://finance.yahoo.com/news/groundbreaking...00564.html

NOTE: $VVOS has NOT PRed this terrific partnership yet.